{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:59:21Z","timestamp":1776214761291,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jbspin.2024.105833","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T16:32:29Z","timestamp":1734798749000},"page":"105833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Early methotrexate treatment for psoriatic arthritis prevention in psoriasis patients\u00a0\u2013\u00a0A retrospective cohort study"],"prefix":"10.1016","volume":"92","author":[{"given":"Danielle","family":"Bar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merav","family":"Lidar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Baum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aviv","family":"Barzilai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Pavlotsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Druyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2024.105833_bib0205","first-page":"369","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2024.105833_bib0210","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/1346-8138.15913","article-title":"Pathophysiology of psoriasis: a review","volume":"48","author":"Yamanaka","year":"2021","journal-title":"J Dermatol"},{"key":"10.1016\/j.jbspin.2024.105833_bib0215","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/1744666X.2018.1468252","article-title":"Quality of life in psoriatic arthritis","volume":"14","author":"Gudu","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jbspin.2024.105833_bib0220","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2021.09.019","article-title":"Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: retrospective analysis of an electronic health records database in the United States","volume":"86","author":"Merola","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jbspin.2024.105833_bib0225","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies","volume":"80","author":"Alinaghi","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jbspin.2024.105833_bib0230","first-page":"213","article-title":"Reducing the risk of developing psoriatic arthritis in patients with psoriasis","volume":"12","author":"Gisondi","year":"2022","journal-title":"Psoriasis (Auckl)"},{"key":"10.1016\/j.jbspin.2024.105833_bib0235","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/annrheumdis-2021-219961","article-title":"Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis","volume":"81","author":"Gisondi","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105833_bib0240","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s40744-024-00680-3","article-title":"From psoriasis to psoriatic arthritis: decoding the impact of treatment modalities on the prevention of psoriatic arthritis","volume":"11","author":"Watad","year":"2024","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jbspin.2024.105833_bib0245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/annrheumdis-2021-220865","article-title":"Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis","volume":"81","author":"Acosta Felquer","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105833_bib0250","first-page":"845","article-title":"Psoriatic arthritis incidence among patients receiving biologic medications for psoriasis: a nested case control study","volume":"1","author":"Shalev Rosenthal","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105833_bib0255","doi-asserted-by":"crossref","first-page":"257","DOI":"10.55563\/clinexprheumatol\/8thj0l","article-title":"Evidence that systemic therapies for psoriasis may reduce psoriatic arthritis occurrence","volume":"38","author":"Solmaz","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105833_bib0260","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/annrheumdis-2021-220865","article-title":"Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis","volume":"81","author":"Acosta Felquer","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105833_bib0265","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/annrheumdis-2021-220761","article-title":"Does biologic therapy impact the development of PsA among patients with psoriasis?","volume":"81","author":"Meer","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105833_bib0270","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/annrheumdis-2021-221255","article-title":"Intercepting psoriatic arthritis in patients with psoriasis: buy one get one free?","volume":"81","author":"McGonagle","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105833_bib0275","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049822","article-title":"IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE)","volume":"11","author":"Eyerich","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jbspin.2024.105833_bib0280","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/jdv.14979","article-title":"Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study","volume":"32","author":"Iversen","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jbspin.2024.105833_bib0285","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3899\/jrheum.200124","article-title":"Methotrexate in psoriasis and psoriatic arthritis","volume":"96","author":"Coates","year":"2020","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.jbspin.2024.105833_bib0290","doi-asserted-by":"crossref","first-page":"102227","DOI":"10.1016\/j.coph.2022.102227","article-title":"Treatment of early rheumatoid arthritis: methotrexate and beyond","volume":"64","author":"Garc\u00eda-Gonz\u00e1lez","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jbspin.2024.105833_bib0295","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(22)01193-X","article-title":"Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"400","author":"Krijbolder","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2024.105833_bib0300","first-page":"469","article-title":"Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire","volume":"27","author":"Ibrahim","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105833_bib0305","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2024.105833_bib0310","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11926-015-0540-1","article-title":"Clinical risk factors for the development of psoriatic arthritis among patients with psoriasis: A review of available evidence","volume":"17","author":"Ogdie","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jbspin.2024.105833_bib0315","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0950-3579(05)80341-3","article-title":"Short-term effects of antirheumatic drugs","volume":"6","author":"Dawes","year":"1992","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105833_bib0320","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13075-015-0697-z","article-title":"Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters","volume":"17","author":"Contreras-Y\u00e1\u00f1ez","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2024.105833_bib0325","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000870","article-title":"Window of opportunity in rheumatoid arthritis \u2013 definitions and supporting evidence: from old to new perspectives","volume":"5","author":"Burgers","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2024.105833_bib0330","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0140-6736(15)00347-5","article-title":"Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial","volume":"386","author":"Coates","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2024.105833_bib0335","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","article-title":"Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition","volume":"15","author":"Scher","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105833_bib0340","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11926-020-00891-x","article-title":"From psoriasis to psoriatic arthritis: insights from imaging on the transition to psoriatic arthritis and implications for arthritis prevention","volume":"22","author":"Zabotti","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jbspin.2024.105833_bib0345","unstructured":"National Psoriasis Foundation. Treatment guidelines. Accessed April 6, 2024. https:\/\/www.psoriasis.org\/psoriasis-guidelines."},{"key":"10.1016\/j.jbspin.2024.105833_bib0350","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3899\/jrheum.2023-0506","article-title":"Can early aggressive treatment of psoriasis prevent psoriatic arthritis? A debate at the GRAPPA Annual Meeting","volume":"50","author":"Soriano","year":"2023","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105833_bib0355","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.3390\/jcm12093271","article-title":"Anti-drug antibodies in the biological therapy of autoimmune rheumatic diseases","volume":"12","author":"Pizano-Martinez","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jbspin.2024.105833_bib0360","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211002685","article-title":"Impact of immunogenicity on clinical efficacy and toxicity profile of biologic agents used for treatment of inflammatory arthritis in children compared to adults","volume":"13","author":"Parikh","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jbspin.2024.105833_bib0365","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/rheumatology\/kead446","article-title":"Psoriatic arthritis risk in psoriasis patients prescribed acitretin versus disease-modifying antirheumatic drugs: a nationwide cohort study","volume":"63","author":"Lin","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2024.105833_bib0370","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","article-title":"The concept of psoriasis as a systemic inflammation: implications for disease management","volume":"26","author":"Reich","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jbspin.2024.105833_bib0375","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/annrheumdis-2017-211625","article-title":"Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study","volume":"77","author":"Nguyen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2024.105833_bib0380","article-title":"Tobacco smoking negatively influences the achievement of greater than three-quarters reduction in psoriasis area and severity index after eight weeks of treatment among patients with psoriasis: findings from a prospective study","volume":"22","author":"Qiang","year":"2024","journal-title":"Tob Induc Dis"},{"key":"10.1016\/j.jbspin.2024.105833_bib0385","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520964024","article-title":"Impact of smoking on psoriasis risk and treatment efficacy: a meta-analysis","volume":"48","author":"Zhou","year":"2020","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jbspin.2024.105833_bib0390","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025481","article-title":"Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients na\u00efve to DMARDs: results from a retrospective cohort study","volume":"100","author":"Floris","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2024.105833_bib0395","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.27758","volume":"63","author":"Saevarsdottir","year":"2011","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2024.105833_bib0400","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X24001441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X24001441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T17:40:41Z","timestamp":1741110041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X24001441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1297319X24001441"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2024.105833","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early methotrexate treatment for psoriatic arthritis prevention in psoriasis patients\u00a0\u2013\u00a0A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2024.105833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\ufffdt\ufffd Fran\ufffdaise de Rhumatologie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105833"}}